SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-15-003254
Filing Date
2015-04-07
Accepted
2015-04-07 16:08:56
Documents
16
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2224070z20-f.htm 20-F 2767842
2 EX-4.29 a2224070zex-4_29.htm EX-4.29 521330
3 EX-4.30 a2224070zex-4_30.htm EX-4.30 1065757
4 EX-4.31 a2224070zex-4_31.htm EX-4.31 274877
5 EX-4.32 a2224070zex-4_32.htm EX-4.32 268602
6 EX-4.33 a2224070zex-4_33.htm EX-4.33 64581
7 EX-4.34 a2224070zex-4_34.htm EX-4.34 64845
8 EX-8.1 a2224070zex-8_1.htm EX-8.1 10111
9 EX-12.1 a2224070zex-12_1.htm EX-12.1 14500
10 EX-12.2 a2224070zex-12_2.htm EX-12.2 13522
11 EX-13.1 a2224070zex-13_1.htm EX-13.1 13633
12 EX-15.1 a2224070zex-15_1.htm EX-15.1 2334
13 G108540.JPG g108540.jpg GRAPHIC 171076
14 G162142.JPG g162142.jpg GRAPHIC 24266
15 G84732KG21I001.JPG g84732kg21i001.jpg GRAPHIC 3038
16 G84732KG21I002.JPG g84732kg21i002.jpg GRAPHIC 3242
  Complete submission text file 0001047469-15-003254.txt   5361331
Mailing Address MEIBERGDREFF 61 AMSTERDAM P7 1005 BA
Business Address MEIBERGDREFF 61 AMSTERDAM P7 1005 BA 31-20-5667394
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-36294 | Film No.: 15756805
SIC: 2834 Pharmaceutical Preparations